Month: October 2009

Why Choice is Important in Healthcare

THESE ARE INTERESTING TIMES IN HEALTHCARE AND LABORATORY TESTING—both here and across the globe. In the United States, elected officials in Congress are busy assembling 1,000-page bills to make over the nation’s entire healthcare system under the guise of extending coverage to those who are currently uninsured. Overseas, the healthcare systems of other developed countries …

Why Choice is Important in Healthcare Read More »

Auckland Health Boards Give DML Some Testing

CEO SUMMARY: Auckland’s chaotic lab testing situation just became more complicated. Today the Auckland District Health Boards announced a four-year contract to allow Diagnostic Medlab to perform 10% of the area’s test volume, primarily for private hospitals and private specialists. Its purpose is to take some pressure off Labtests by having Diagnostic Medlab perform the …

Auckland Health Boards Give DML Some Testing Read More »

Expert Says Time is Now For Labs to Adopt QMS

CEO SUMMARY: Laboratories in the United States are knowledgeable about the use of quality control (QC) and quality assurance (QA) programs. But QC and QA represent only two small parts of a comprehensive quality management system (QMS), says Lucia Berte, an expert in lab quality. One benefit for clinical laboratories using a QMS is that …

Expert Says Time is Now For Labs to Adopt QMS Read More »

Scripps’ Tumor Board Finds Value in Digital Imaging of Slides

CEO Summary: When the Pathology Department at Scripps Memorial Hospital in La Jolla, California, was considering the purchase of a digital imaging system, it gained unlikely allies. Non-pathologist physicians participating in the department’s tumor boards advocated for the purchase after seeing a demonstration. Pathologists at Scripps are preparing for a future in which digital imaging …

Scripps’ Tumor Board Finds Value in Digital Imaging of Slides Read More »

Bureaucratic System in Ireland Affects Access to Pap Testing

WHEN IT COMES TO CERVICAL CANCER SCREENING IN IRELAND, health system bureaucrats have put some of the nation’s women into the perfect “Catch 22.” As this happens, it provides another case study of why a government health system can often create coverage rules and restrictions which run contrary to common sense in patient care, while …

Bureaucratic System in Ireland Affects Access to Pap Testing Read More »

GSK and Abbott Team up For Companion Diagnostic

CEO SUMMARY: Although GlaxoSmithKline PLC is several years away from having a deliverable product from its Antigen Specific Cancer Immunoassay (ASCI) Program, it has a development deal with Abbott Laboratories to produce a companion diagnostic test for ASCI-based products. The interesting twist in this arrangement is that the resulting companion diagnostic assay will be designed …

GSK and Abbott Team up For Companion Diagnostic Read More »

Dark Daily

October 12, 2009 “Intelligence: Late Breaking Lab News”

In the continuing saga of health reform efforts in Washington, DC, the clinical laboratory industry got a bit of good news, at least for the moment. In recent weeks, the Senate Finance Committee removed a provision to raise $750 million annually by enacting a tax on clinical lab revenue. The proposed tax was eliminated after …

October 12, 2009 “Intelligence: Late Breaking Lab News” Read More »